LONDON, Jan. 18, 2016 /PRNewswire/ -- Japan Contract Research Organization Market : Aging Population and Liberal Regulations will Propel Clinical Trial Growth
This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management.
Clinical Development Spending
In 2014, the Japanese clinical research organization (CRO) market generated $ million in revenue. It is expected to grow at a CAGR of %, to reach $ million in 2019.
Clinical Development— Main Trends
From the clinical trial perspective, Japan is already a mature and experienced market that aims to maintain its international competitiveness. - The CRO market in Japan remains lucrative and continues to attract both foreign and domestic pharmaceutical companies as well as CROs. - Changes are on-going to make Japan a major clinical trial hub by improving the cost, speed, and quality of clinical trials.
MNC and Local Pharmaceutical Companies
The CRO industry in Japan consists of both local and multinational CROs that continue to leverage the growing pharmaceutical and clinical trial markets.- A common practice for multinational CROs is to acquire or partner with a local CRO to immediately obtain an experienced team with local knowledge.- Usually, Japanese CROs handle local projects, and global CROs take advantage of their capabilities and use their own global reach to win international projects.
Download the full report: https://www.reportbuyer.com/product/3180764/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers